Showing 1 to 4 of 4 results
Health Canada vows to expedite biosimilar drug approvals to reduce costs
Health Canada is addressing a backlog in biosimilar drug approvals, aiming to accelerate the market entry of cheaper alternatives to costly biologic drugs, driven by a 400 percent surge in submissions since 2016 and a need to reduce costs for public drug plans.
Health Canada vows to expedite biosimilar drug approvals to reduce costs
Health Canada is addressing a backlog in biosimilar drug approvals, aiming to accelerate the market entry of cheaper alternatives to costly biologic drugs, driven by a 400 percent surge in submissions since 2016 and a need to reduce costs for public drug plans.
Progress
20% Bias Score
Alberta's $70M Drug Import Deal Under Investigation
Alberta's $70-million deal to import medication from Turkey is under scrutiny due to a lack of Health Canada approval and allegations of government interference in health contracts; investigations are underway by the RCMP, Auditor-General, and a third party.
Alberta's $70M Drug Import Deal Under Investigation
Alberta's $70-million deal to import medication from Turkey is under scrutiny due to a lack of Health Canada approval and allegations of government interference in health contracts; investigations are underway by the RCMP, Auditor-General, and a third party.
Progress
40% Bias Score
Alberta's \$70-Million Children's Medicine Import: A Costly Miscalculation
Alberta spent \$70 million importing five million bottles of children's pain relief medication from Turkey in 2022, despite warnings of potential financial loss; only 1.5 million bottles were used, prompting investigations into improper contracting.
Alberta's \$70-Million Children's Medicine Import: A Costly Miscalculation
Alberta spent \$70 million importing five million bottles of children's pain relief medication from Turkey in 2022, despite warnings of potential financial loss; only 1.5 million bottles were used, prompting investigations into improper contracting.
Progress
60% Bias Score
FDA Bans Red No. 3 Food Dye Despite Lack of Human Cancer Link
The U.S. FDA banned Red No. 3, a synthetic food dye, from its food supply by January 15, 2027, due to the Delaney Clause, which prohibits food additives shown to cause cancer in animals even without evidence of human harm; Canada, however, continues to permit its use within specific limits.
FDA Bans Red No. 3 Food Dye Despite Lack of Human Cancer Link
The U.S. FDA banned Red No. 3, a synthetic food dye, from its food supply by January 15, 2027, due to the Delaney Clause, which prohibits food additives shown to cause cancer in animals even without evidence of human harm; Canada, however, continues to permit its use within specific limits.
Progress
36% Bias Score
Showing 1 to 4 of 4 results